Autoimmune polyglandular syndrome type 3 variant in rheumatoid arthritis

1. MICHELS AW., GOTTLIEB PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010; 6(5):270–7.10.1038/nrendo.2010.40Search in Google Scholar

2. KAHALY GJ., FROMMER L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018; 41(1):91–98.10.1007/s40618-017-0740-9Search in Google Scholar

3. HUBER A., MENCONI F., CORATHERS S., JACOBSON EM., TOMER Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008; 29(6):697–725.10.1210/er.2008-0015Search in Google Scholar

4. GRUBIC Z., ROJNIC PUTAREK N., MASKALAN M., ZUNEC R., STINGL JANKOVIC K., BUREK KAMENARIC M., et al. Human Leukocyte Antigen class II polymorphisms among Croatian patients with type 1 diabetes and autoimmune polyglandular syndrome type 3 variant. Gene. 2018; 674:93–97.10.1016/j.gene.2018.06.083Search in Google Scholar

5. D’ANTONA L., et al. Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT Study. Medicine (Baltimore). 2016; 95(7):e2552.10.1097/MD.0000000000002552Search in Google Scholar

6. DOUGADOS M., SOUBRIER M., ANTUNEZ A., BALINT P., BALSA A., BUCH MH., et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014; 73(1):62–8.10.1136/annrheumdis-2013-204223Search in Google Scholar

7. NAIK RG., BROOKS-WORRELL BM., PALMER JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab. 2009; 94(12):4635–44.10.1210/jc.2009-1120Search in Google Scholar

• Glycemic control as the main determinant factor of serum VEGF levels in type 2 diabetes mellitus patients
• Cardio-Oncology for the Primary Care Provider
• The correlation between Body Mass Index and histological features of Nonalcoholic Fatty Liver Disease
• Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report
• Evaluation of Reliability and Validity of the RALE and BRIXIA Chest-X Ray Scores in Patients Hospitalized with COVID-19 Pneumonia